m-PEG3-NHS ester is a reactive ADC linker combining a PEG3 spacer with an NHS ester group. It enables efficient amine-targeted conjugation, enhancing payload attachment and linker stability in advanced antibody-drug conjugate synthesis and development.
Structure of 876746-59-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
m-PEG3-NHS ester is a widely used reagent in bioconjugation and protein modification applications. Here are some key applications of m-PEG3-NHS ester:
Protein Modification: m-PEG3-NHS ester is commonly used for the PEGylation of proteins, which involves attaching polyethylene glycol (PEG) chains to proteins to improve their solubility, stability, and half-life in biological systems. This modification reduces immunogenicity and enhances therapeutic efficacy, making it beneficial in drug development. By reacting with primary amines on proteins, m-PEG3-NHS ester facilitates the creation of stable and biocompatible protein derivatives.
Surface Coating: m-PEG3-NHS ester is employed in surface functionalization of biomaterials and medical devices to create anti-fouling and biocompatible coatings. By covalently bonding PEG chains to surfaces, it minimizes protein adsorption and cell adhesion, reducing the risk of biofouling and improving the material’s performance. This application is crucial in biomedical devices such as catheters and implants to reduce rejection and increase the longevity of the device.
Drug Delivery Systems: m-PEG3-NHS ester is utilized in the development of drug delivery systems, including nanoparticles and liposomes, to affect the pharmacokinetics and biodistribution of drugs. By PEGylating the surface of these delivery vehicles, it enhances their circulation time and reduces clearance by the reticuloendothelial system. This leads to improved targeting of therapeutic agents to specific tissues or cells, increasing the effectiveness of the treatment.
Diagnostic Applications: In diagnostic assays, m-PEG3-NHS ester can be used to modify antibodies or other proteins involved in the detection of analytes. The PEGylation prevents non-specific binding and increases the stability of diagnostic proteins, leading to more accurate and reliable assays. This is especially useful in the development of better-performing biosensors and immunoassays for clinical and research purposes.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00512 | m-PEG1-NHS ester | 1027371-75-0 | |
BADC-00519 | m-PEG2-NHS ester | 1127247-34-0 | |
BADC-00583 | mPEG9-NHS ester | 1316189-13-5 | |
BADC-00954 | mPEG6-NHS ester | 1449390-12-8 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.